Market revenue in 2023 | USD 16.1 million |
Market revenue in 2030 | USD 26.0 million |
Growth rate | 7.1% (CAGR from 2023 to 2030) |
Largest segment | Volumetric infusion pumps |
Fastest growing segment | Insulin Infusion Pumps |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Volumetric Infusion Pumps, Syringe Infusion Pumps, Insulin Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient-Controlled Analgesia Infusion Pumps, Implantable Infusion Pumps, Other Infusion Pumps |
Key market players worldwide | Baxter International Inc, B. Braun, Medtronic PLC, Micrel Medical Devices, Boston Scientific Corp, Fresenius SE & Co KGaA, Roche Holding AG, Tandem Diabetes Care Inc, Terumo Corp, Moog Inc A, IRadimed Corp, CareFusion, Smiths Group PLC, Mindray Medical International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous infusion pumps market will help companies and investors design strategic landscapes.
Volumetric infusion pumps was the largest segment with a revenue share of 16.77% in 2023. Horizon Databook has segmented the New Zealand intravenous infusion pumps market based on volumetric infusion pumps, syringe infusion pumps, insulin infusion pumps, enteral infusion pumps, ambulatory infusion pumps, patient-controlled analgesia infusion pumps, implantable infusion pumps, other infusion pumps covering the revenue growth of each sub-segment from 2018 to 2030.
According to a study conducted by the University of Otago, 59% of New Zealand’s public health expenditure was on chronic diseases in 2019. The study also estimated that multimorbidity will increase in proportion to the increase in life expectancy of individuals.
Cardiovascular diseases affect the majority of the patients, followed by cancer, chronic respiratory disease, and diabetes. According to a survey conducted by New Zealand’s Ministry of Health, approximately 3,000 cardiac surgical procedures were carried out in 2018 and 70% of the surgeries were performed on patients aged 60 years and above.
New Zealand’s health system is responding promptly to this change and is adopting advanced medical devices to tackle the increasing number of patients. The country has undertaken healthcare agreements, which can help in subsidizing pharmaceuticals medicine and medical devices.
Horizon Databook provides a detailed overview of country-level data and insights on the New Zealand intravenous infusion pumps market , including forecasts for subscribers. This country databook contains high-level insights into New Zealand intravenous infusion pumps market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account